Management Board ǀ Apogenix

Apogenix develops innovative protein therapeutics for the treatment of cancer and other malignant diseases. Our lead drug candidate APG101 has demonstrated a statistically significant efficacy in a controlled phase II trial in recurrent glioblastoma.

The Handbook of Board Governance: A Comprehensive Guide for Public, Private, and Not-for-Profit Board Members: Leblanc, Richard: 9781118895504: Books

Governance in a Changing Environment

Immuno-Oncology Overview ǀ Apogenix

The Perfect Corporate Board: A Handbook for Mastering the Unique Challenges of Small-Cap Companies: 9780071799546: Epstein, Adam: Books

Clinical Candidates ǀ Apogenix

Apogee DA-16-X

Gene expression profiles in genome instability-based classes of colorectal cancer, BMC Cancer

Investors ǀ Apogenix

How to use the Mixer to directly monitor inputs?